Navigation Links
Osteotech Reports 2007 Full Year and Fourth Quarter Financial Results; Full Year Revenue of $104.3 Million Exceeds $100 Million Milestone; Diluted Earnings Per Share Was $.15 in 2007
Date:2/20/2008

torical facts contain forward-looking statements (as such are defined in the Private Securities Litigation Reform Act of 1995) regarding the Company's future plans, objectives and expected performance. Any such forward-looking statements are based on assumptions that the Company believes are reasonable, but are subject to a wide range of risks and uncertainties and, therefore, there can be no assurance that actual results may not differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially include, but are not limited to, the Company's ability to develop and introduce new products, differences in anticipated and actual product and service introduction dates, the ultimate success of those products in the marketplace, the continued acceptance and growth of current products and services, the impact of competitive products and services, the availability of sufficient quantities of suitable donated tissue and the success of cost control and margin improvement efforts. Certain of these factors are detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. All information in this press release is as of February 20, 2008 and the Company does not intend to update this information.

OSTEOTECH, INC. and Subsidiaries

CONSOLIDATED STATEMENTS OF OPERATIONS

(dollars in thousands, except per share data)

Three Months Year Ended

Ended December 31, December 31,

2006

2007 (restated) 2007 2006

Revenue $ 26,939 $ 25,431 $104,277 $ 99,241

Cost of revenue 12,532 13,322 50,555 51,439

Gross profit
'/>"/>

SOURCE Osteotech, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Osteotech Announces Fourth Quarter and Full Year Earnings Release and Conference Call Schedule
2. Osteotech to Present at Sidoti Conference in San Francisco
3. Osteotech to Present at Roth Capital Partners 2007 New York Investor Conference
4. Neurobiological Technologies Reports $2.1 Million Quarterly Payment for Sales of Memantine
5. Amsterdam Molecular Therapeutics Reports Full Year Results 2007
6. Medivation Reports Year-End 2007 Financial Results and Pipeline Progress
7. United Therapeutics Reports Fourth Quarter and Annual 2007 Financial Results
8. Favrille Reports Fourth Quarter and Year End 2007 Financial Results
9. JADO Reports Clinical Proof of Concept With Raft Modulator in Atopic Dermatitis
10. OrbusNeichs Genous(TM) Bio-Engineered R Stent(TM) is Feasible in Acute Myocardial Infarction Patients, American Heart Journal Paper Reports
11. Senesco Technologies Reports Second Quarter Fiscal 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/15/2014)... Look inside the new Preferred Solutions® ... lab, from fluid handling to instruments to supplies. Many ... you order. , Preferred Solutions features a full ... L/S® model for precise flow control and dispensing to ...
(Date:1/15/2014)... England , January 15, 2014 A ... win races on the Formula 1 track could help to ... McLaren Applied Technologies (MAT), Stowhealth (a GP surgery based in ... by healthcare provider Simplyhealth. Telemetry technology, which is ...
(Date:1/15/2014)... 15, 2014 2013 was a banner ... State Technologies®. They saw continued independent research led by ... were awarded a $1 million grant from the Susanne ... and Behavior” a peer reviewed journal, Amy Grant highlighted ...
(Date:1/14/2014)... Washington, DC (PRWEB) January 14, 2014 ... session for Thursday, January 23, 2014 at 2pm EST ... Actionable Knowledge.” The topic focuses on how technology can ... mission critical decisions for government agencies. The online webinar ...
Breaking Biology Technology:Cole-Parmer Begins 2014 with the Release of Preferred Solutions 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 2Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 3Formula 1 Technology Tackles Obesity in Unique Healthcare Partnership 4Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 2Dynamic Innovative Technology Showcased at Scottsdale Company’s Open House 3Webcast - Natural Language Processing: Converting Raw Data into Actionable Knowledge – Hosted by Carahsoft and CDS Federal Services 2
... young company with a preventive solution to identity theft took ... Burrill Technology Business Plan Competition, but if area investors want ... act quickly. , , Din and Newport stand in ... Khaja M. Din, president IPIC (Internet Privacy & ...
... of capturing 10 percent of the stem cell technology market ... directing the Department of Commerce to spend at least $5 ... companies to Wisconsin. , ,Doyle said the executive order, signed ... to stem cell research. Proponents of stem cell research cite ...
... and services to the financial and health-benefits industries, said ... to $1.1 billion. , ,Net income was $116 million, ... in the first quarter of 2005 on $973 million ... included repurchasing 5.4 million shares of common stock and ...
Cached Biology Technology:Winner of Burrill competition courted by North Carolina investors 2Winner of Burrill competition courted by North Carolina investors 3Doyle authorizes $5 million to woo stem cell companies 2
(Date:7/9/2014)... high levels of vitamin D in their blood are more ... Patients with the highest levels of vitamin D have half ... levels, the findings reveal. , The study is the first ... cancer patients after their diagnosis which includes that produced ... with their long term survival prospects. , The ...
(Date:7/9/2014)... data can yield big savings, if they are ... Bates of the Brigham and Women,s Hospital and ... for cost savingshigh-cost patients; readmissions; triage; decompensation (when ... optimization when a disease affects multiple organ systems. ... though the current costs associated with all six ...
(Date:7/8/2014)... increased risk of severe perineal tearing during childbirth in women ... a new study published today (9 July) in BJOG: ... This study, investigates among women who have had a third ... subsequent pregnancies and the recurrence of severe perineal tears. ... in some women the tear may be more extensive. A ...
Breaking Biology News(10 mins):The impact of big data on health care: Health Affairs' July issue 2Mode of delivery following a perineal tear and recurrence rate in subsequent pregnancies 2
... Mich.---Researchers have developed what they believe is the first new ... used to treat all HIV patients, which could eventually lead ... the University of Michigan used computer models to develop the ... compound does indeed inhibit HIV protease, which is an established ...
... Oregon white oak were once widespread in the Pacific ... Fire suppression, conifer and invasive plant encroachment, and land ... much as 99 percent of the oak communities historically ... new technical report titled "Evaluation of Landscape Alternatives for ...
... experts on evolution will gather in Minnesota June 20 ... gathering of evolutionary biologists. The conference, the premier international ... is sponsored by the University of Minnesota,s Bell Museum ... and Minnesota Citizens for Science Education. Headlining the ...
Cached Biology News:Compound has potential for new class of AIDS drugs 2University of Minnesota to host world's largest conference on evolution 2
... numbers of samples may be carried out using ... minimum operator attention. System control and data ... CE 4900. The elegant, powerful and very ... and Windows 98 and 2000., The supplied automatic ...
Heavy-duty rim. Especially recommended as a titration flask. Corning5100. capacity 250 mL Special grade: student grade...
This CLS number is a new product number, created to easily match Cornings product number. If showing no availability yet, please order under the old Sigma-Aldrich number (F1676) or contact customer s...
Mouse monoclonal [YPF19] to Yersinia pestis F1 antigen ( Abpromise for all tested applications)....
Biology Products: